A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Abacavir sulfate

Trial Locations (6)

Group Hospier Pitie-Salpetriere / Maladies Infec et Trop, Paris

Groupe Hospitalier Bichat-Claude Bernard, Paris

Hopital de Purpan / CHU de Rangueil / Medecine Interue, Toulouse

Hopital de Purpan / Service du Professeur Auvergnat, Toulouse

Universitat Erlangen, Erlangen

Universitatsklinikurn Frankfurt, Frankfurt